Latest news

Simultaneous introduction is first in African history.  [Français] [Deutsch]

Partners leading efforts to control measles announce a new global strategy aimed at reducing measles deaths and congenital rubella syndrome to zero (Joint American Red Cross/CDC/UN Foundation/UNICEF/ WHO press release).

Special supplemental issue of the journal Vaccine provides critical insights on rotavirus vaccine performance to help maximize their impact in developing countries.

GAVI CEO's speech to ational Institute of Allergy and Infectious Diseases focuses on need for equity in vaccine coverage.

Accountability report singles out GAVI for its 'unified focus', IFFIm as a 'catalytic success story' and and the AMC as a 'game-changer'.

Tailored approach required to ensure routine immunisation reaches 19.3 million children who miss out every year.

Gender target achieved and executive committee process to be streamlined.

GAVI expresses appreciation to Comic Relief for a new grant and raising visibility for immunisation.

Statement by GAVI Alliance CEO, Seth Berkley M.D. [日本語]

Sudan recently became the first of many GAVI-eligible countries in Africa to introduce a new vaccine to protect children from rotavirus, the leading cause of severe infant diarrhoea.

Health workers and Ministry of Health officials in Tanzania have are gearing up for a huge task as they prepare to introduce a new vaccine against rotavirus, the leading cause of severe infant diarrhoea.

With nine women and nine men, an independent review committee (IRC) to monitor country progress is GAVI’s first committee to have a gender balance and marks another step forward for gender policy.